Profound Medical Corp.
PROF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 41.2% | 7.8% | -2.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 65.9% | 60.9% | 45.2% | 43% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -251.7% | -372% | -398.2% | -416.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -260.4% | -396.8% | -429.1% | -446.7% |
| EPS Diluted | -1.07 | -1.35 | -1.38 | -1.5 |
| % Growth | 20.7% | 2.2% | 8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |